All posts by imreal

Enzee Health (formerly ZapIT! Medical) Secures Funding to Help Hospitals Improve Quality Assurance and Compliance Management


News Image

This funding from leading investors in healthcare innovation allows us to expand the availability of our ground-breaking solution that helps to quantify quality for healthcare systems of any size, anywhere.

Today, Enzee Health, formerly ZapIT! Medical, the leading cloud-based platform that helps measure compliance and quality to help hospitals provide better patient care, is announcing it has secured $1.5MM in seed financing, led by Rev1 Ventures with participation from Tamarind Hill, Harbor Street Ventures, M7 NEO, Redgrave Investments, Service Provider Capital and others. Enzee empowers hospital personnel to easily perform and track required quality testing within departments, eliminating the inefficiencies of paper record keeping, and making it easier for administrators to assess whether departments are compliant with quality standards and are inspection ready.

“This funding from leading investors in healthcare innovation allows us to expand the availability of our ground-breaking solution that helps to quantify quality for healthcare systems of any size, anywhere,” said Bryon Murray, CEO of Enzee Health. “By bringing together all of their data, from all of their systems, hospitals can better understand their quality assurance compliance management processes to ensure standards are being met and improving the quality of their care.”

Enzee’s data management platform, ZapIT, automates quality control (QC) testing and maintains quality assessment (QA) data for all modalities in radiology and radiation oncology, in addition to managing records for all devices and processes of the QA program. Using Enzee’s ZapIT, hospitals are streamlining workflows and freeing up high-level clinical personnel to attend to other tasks. The app provides a first-class, comprehensive quality assurance practice management system for medical imaging, radiation oncology, and radiation safety. With this funding round, Enzee Health can expand into all departments to deliver comprehensive quality data into one platform for hospitals.

“We are excited to be partnering with Enzee Health and thrilled to have led its seed round – Bryon, Mike, and their team have deep expertise in managing quality assurance and compliance related to complex diagnostic equipment that is critical to delivering patient care,” said Ryan Helon, Executive Vice President, Investment Funds at Rev1 Ventures. “Enzee has a great understanding of the needs of healthcare providers now and into the future, and is well positioned to deliver value to its customers,” “We seek out companies that are built to scale and innovate – Enzee Health has the team and vision to do both.”

The company recently rebranded and launched a new website to reflect its broader approach of providing the same features that address the radiology and radiation oncology markets to supporting the entire hospital QA program, including connecting to existing compliance and test tracking apps, providing a holistic picture of a facility’s compliance and quality across personnel and departments.

“Enzee Health aligns well with our focus on supporting companies who are bringing innovative technology to healthcare providers that unlock efficiency, accuracy, and better patient experiences. Enzee is building what we believe is the start of an industry-changing approach to hospital compliance and QA,” said Mark Shary, Managing Partner at Tamarind Hill. “Bryon and the team have tapped into what is likely to become table stakes for how healthcare facilities manage compliance and quality assurance standards, and we’re excited to help them bring their capabilities to more markets as they grow.”

In order to keep pace with demand, the financing will support the additions of key hires to the Enzee Health team, including appointments in development, sales, and marketing.

About Enzee Health

Enzee Health enables better quality healthcare through data. Enzee’s cloud-based platform helps measure compliance and quality across multiple modalities giving hospitals the power to provide better patient care. Its innovative technology allows hospital personnel to easily perform and track required quality testing within departments, eliminating the inefficiencies of paper record keeping and making it simple for administrators to assess whether departments are compliant with quality standards and inspection ready. For more information, visit https://www.enzeehealth.com/

Share article on social media or email:

Cura Surgical Awarded Vizient Innovative Technology Contract


Argentum Medical, dba Cura Surgical, a privately held medical device company, announced that its Silverlon Antimicrobial Dressings has received an Innovative Technology contract from Vizient, Inc.

Cura Surgical is honored by this recognition and proud of our Silverlon products that demonstrate unique qualities and differentiators from other antimicrobial dressings on the market.

Argentum Medical, dba Cura Surgical, a privately held medical device company, announced that its Silverlon Antimicrobial Dressings has received an Innovative Technology contract from Vizient, Inc., the largest member-driven health care performance improvement company in the country. The contract was based on the recommendation of Silverlon by healthcare clinicians in this category.

Innovative technology contracts are recommended after review and interaction with products submitted through Vizient’s Innovative Technology program. Cura Surgical had the privilege to present Silverlon Antimicrobial Dressings at the Vizient Innovative Technology Exchange last September. The exchange offers selected suppliers the unique opportunity to demonstrate their technologies to supply chain and clinical leaders from Vizient’s member hospitals and subject matter experts who serve on their supply councils. Each technology showcases how it improves clinical outcomes, enhances safety or drives incremental improvements to health care delivery or business models.

“Our goal is to help healthcare professionals provide the highest level of care for their patients,” states Raul Brizuela, President and CEO of Cura Surgical. “We are honored by this recognition and proud of our products that demonstrate unique qualities and differentiators from other antimicrobial dressings on the market.”

Silverlon’s Innovative Technology recognition by Vizient is further validated by the U.S. Food and Drug Administration’s (FDA) 2021 Breakthrough Device Designation for Silverlon Wound Contact and Burn Contact Dressings. This FDA designation is an exceptional status provided to certain devices and device-led combination products that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions, granted to only 206 devices in 2021.

Silverlon dressings contain 50-100 times more pure silver than other silver-impregnated dressings and are backed by published clinical studies in numerous specialties. The unique action of ionic silver makes it an ideal element in an antimicrobial dressing. Originally developed to treat burn and blast injuries for the U.S. military, Silverlon dressings are now used throughout the world by surgeons and other healthcare professionals on surgical wounds, burn, vascular access, circulatory support and in negative pressure wound therapy.

“A product receives this type of contract when it demonstrates a unique quality that differentiates it from other products on the market,” said Kelly Flaharty, senior director of contract process for Vizient. “Our member council determined that Silverlon Antimicrobial Dressings met this standard and recognizes its potential to improve quality outcomes.”

Vizient represents a diverse membership base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents more than $130 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with member-led councils and task forces to evaluate products for their potential to bring real innovation to health care. Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.

About Cura Surgical

Cura Surgical, an Argentum Medical company, pioneered the use of silver-plated nylon. Specializing in the development of innovative products made from silver-plated nylon, the company continues to explore new applications and markets for its Silverlon technology in keeping with its corporate mission to improve clinical outcomes.

###

Share article on social media or email:

Emerging Applications for Liquid Biopsy in Drug Development, Upcoming Webinar Hosted by Xtalks


Due to advances in next-generation sequencing for evaluation of the human genome, comprehensive analyses of circulating tumor DNA (ctDNA) through the liquid biopsy, represents a minimally invasive means to diagnose cancer.

Precision oncology represents a mainstay for cancer treatment through the targeting of specific molecular and genetic alterations associated with a patient’s tumor. With the emergence of pan-solid tumor approvals for immunotherapies such as pembrolizumab and receptor kinase inhibitors such as larotrectinib, it is the biomarkers themselves rather than the individual tumor type that is predictive of response to therapy and represents an exciting time in the war on cancer. With more than 50 percent of all new therapy approvals classified as precision medicines, there is an increased need to identify patient populations most likely to benefit from therapy, as well as maximize patient access to these treatments. Due to advances in next-generation sequencing for evaluation of the human genome, comprehensive analyses of circulating tumor DNA (ctDNA) through the liquid biopsy, represents a minimally invasive means to diagnose cancer.

A liquid biopsy can detect mutations associated with treatment selection, monitor tumor evolution and predict disease recurrence or relapse. Due to the broad range of ctDNA applications, these liquid biopsy analyses enable a valuable tool to facilitate therapeutic development and expedite access to life-saving treatments for patients.

This webinar will highlight the different areas where liquid biopsy analyses are being applied in drug development today, including in advanced-stage disease for patient selection or stratification, evaluating treatment efficacy and understanding underlying genetic mechanisms of clinical response and resistance to guide future treatment strategies.

Register to learn about the emerging applications for liquid biopsy, including evaluation of molecular residual disease in early-stage cancer.

Join experts from Labcorp, Taylor Jensen (moderator), PhD, Vice President, Head of Oncology Science; and Mark Sausen, PhD, Executive Director, Head of Technology Innovation, PGDx, for the live webinar on Wednesday, October 5, 2022, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Emerging Applications for Liquid Biopsy in Drug Development.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Transforming EHR Data with AI, Upcoming Webinar Hosted by Xtalks


Structuring this free-form data has the immense opportunity to provide deeper insights into many aspects of patients’ disease journeys, adverse events identification, burden-of-disease tracking and patient identification for a clinical study and more.

For real-world data (RWD) to be useful at scale to drive business insights, it often needs to be deemed as ‘quality’ data. Transforming     RWD into a quality data asset often requires it to be organized, cleansed, harmonized and essentially structured in a format that makes it usable. While claims data is predominantly in a structured format, electronic health record (EHR) data contains both structured and unstructured data. In fact, it is estimated that 80 percent of this type of data is unstructured, often in the form of free-text.

This notes-based data can include important clinical information, such as patient sentiment, genetic testing results, reasons for therapy choice, side effects of a medication, patient outcomes and more. Structuring this free-form data has the immense opportunity to provide deeper insights into many aspects of     patients’ disease journeys, adverse events identification, burden-of-disease tracking     and patient identification for a clinical study and more. Artificial intelligence (AI) techniques, such as machine learning (ML) and natural language processing (NLP), paired with oversight from clinicians, are already being used to standardize EHR data in a meaningful way at scale.

Join this webinar to understand how unstructured EHR data is curated using clinician-informed AI to help make it meaningful for real-world research purposes.

Bonus: hear real case study examples across ophthalmology, urology and neurology.

Join Michael Mbagwu, MD, Medical Director, Verana Health; Aracelis Torres, PhD, Senior Vice President of Customer Solutions and Quantitative Sciences, Verana Health; and Abel Kho, MD, Founding Director, Institute for Augmented Intelligence in Medicine, for the live webinar on Wednesday, October 5, 2022, at 4pm EDT (1pm PDT).

For more information, or to register for this event, visit Structuring the Unstructured in RWE: Transforming EHR Data with AI.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Optimizing Clinical Supply Chain Management, Upcoming Webinar Hosted by Xtalks


Register to explore the underlying causes of clinical supply chain management problems and discuss best practices to optimize them.

Today’s clinical trials are more complex, requiring 65 to 85 percent more procedures, endpoints, collected data points and research sites than a few years ago. This complexity creates logistical challenges for clinical operations teams that result in a variety of problems. For example, sites not having IP for a patient visit, expired lab kits, lost biological samples and delayed resupply shipments. These clinical supply chain management problems contribute to increased costs, reduced productivity, decreased patient retention and threaten the success of clinical trials.

In this webinar, the featured speakers will cover the following topics: Facilitating collaboration between sponsors, CROs, sites, labs, vendors and biorepositories; Obtaining real-time visibility into the location and status of IP, lab kits, samples and supplies; Gaining traceable chain-of-custody for biological samples, IP, lab kits and supplies; And ensuring compliance through protocol adherence and amendment harmonization.

Register to explore the underlying causes of clinical supply chain management problems and discuss best practices to optimize them.

Join experts from Slope, Hope Meely, Chief Clinical Officer; and Ethan Seville, Solutions Architect, for the live webinar on Wednesday, October 5, 2022, at 2pm EDT (11am PDT).

For more information, or to register for this event, visit Optimizing Clinical Supply Chain Management.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Maptician Releases Conference Room Signage Integration to Power End-to-End Hybrid Office Solution


News Image

Maptician, the market leading end-to-end technology solution for the hybrid workplace, announces the addition of conference room signage to the Maptician platform, providing firms an end-to-end technology solution to manage their hybrid office operations. Maptician is the all-in-one software solution for the hybrid workplace, from office hoteling, conference room management and employee collaboration, to innovative scenario planning and powerful reporting and analytics features that help organizations make great decisions.

According to Cushman & Wakefield’s Bright Insights, 75% of organizations are implementing versions of hoteling or flexible work models. Legacy space planning platforms were not built to help organizations succeed in hybrid operations, especially as organizations must continuously evolve and learn what models help them be most successful. As a result, many organizations are cobbling together several, non-integrated solutions to manage their evolving strategies.

Maptician is an innovative technology built to make hybrid operations successful. An end-to-end solution for the hybrid workplace, Maptician enables intelligent decisions about people and space, including real estate reduction and reconfiguration, facilitates culture-specific hoteling strategies that promote in-office collaboration and networking, and provides reporting and analytics for finance professionals all in the industry’s simplest, most user-friendly UX.

With the addition of conference room signage, Maptician further enables organizations to leverage an end-to-end solution for their hybrid office. The conference room signage integration connects to any internet accessible device, including iPads and Android devices, enabling users to:

  • View live office maps to see whether a conference room is currently in use (red), available (green), book times both in real time and in the future.
  • Find a Room. The Find a Room page allows users to search for existing and available conference room reservation times.
  • View conference/meeting room information including capacity, size, location, Wi-Fi name & password, features, equipment, accessibility and restrictions.

Maptician Chief Executive Officer, Alaa Pasha, comments, “Our mission is to help make hybrid operations, simple, easy and successful. We’re delighted to add conference room signage features to further enable clients to leverage one, single innovative platform built for the modern workplace and help them stop struggling with inefficient legacy technologies. We love growing alongside our clients and look forward to continuously bringing more value to the Maptician platform.”

About Maptician

Maptician makes hybrid operations work by empowering companies to make great decisions about people and spaces. An end-to-end solution for the hybrid workplace, Maptician enables intelligent decisions about real estate reduction and reconfiguration, facilitates culture-specific hoteling strategies that promote in-office collaboration and networking, and provides reporting and analytics for finance professionals in the industry’s simplest, most user-friendly UX.

Share article on social media or email:

Community Health Centers of Arkansas Selects HealthTalk A.I. For Patient Engagement


News Image

We needed a partner who really understood the challenges facing health centers. – Dr. Kellee Farris, Chair of the CHCA Steering Committee and CEO of Lee County Cooperative Clinic

HealthTalk A.I., a leading patient engagement company, today announced it has been selected as the patient engagement vendor of choice by Community Health Centers of Arkansas (CHCA).

CHCA is a Primary Care Association (PCA) that provides advocacy, training, and support for community health centers (CHCs) located throughout Arkansas. This partnership will provide preferred access to the HealthTalk A.I. platform, helping CHCA member health centers improve access to care and reduce health disparities for underserved Arkansans.

“We needed a partner who really understood the challenges facing health centers,” said Dr. Kellee Farris, Chair of the CHCA Steering Committee and CEO of Lee County Cooperative Clinic. “HealthTalk A.I. has a successful track record working with CHCs and delivers a solution that’s flexible and built for today’s healthcare consumer. We’re confident that the HealthTalk A.I. platform will help our members expand access, close more care gaps, and improve the patient experience for the unique communities they serve.”

HealthTalk A.I. was formed to change the way patients and providers connect. Their patient engagement platform helps healthcare organizations drive quality by scaling outreach and scheduling encounters with the appropriate resource. The ability to aggregate the data and deliver actionable information makes it an excellent fit for PCAs or Health Center Controlled Networks (HCCNs) looking to implement a state-level program.

“We’re thrilled to have been selected by CHCA and are excited to get to work,” said Jerrod Ullah, CEO and founder of HealthTalk A.I. “CHCs play an integral role in delivering equitable care to underserved communities and this allows us to push forward with our mission to expand access for all patients regardless of background or language.”

About Community Health Centers of Arkansas:

Community Health Centers of Arkansas (CHCA) provides advocacy, training, and support for 12 CHC organizations and their 190+ service locations. To learn more about CHCA, visit http://www.chc-ar.org.

About HealthTalk A.I.:

HealthTalk A.I. helps healthcare providers improve access to care and intervene like never before possible. Their fully-automated, omni-channel platform delivers user-friendly communication with messages and rules configured by each healthcare organization. This gives providers the ability to engage their entire population and close the loop with customer recovery actions and clinical encounters. To learn more, visit HealthTalkAI.com. Watch this video to see how HealthTalk A.I. supports health centers. Follow HealthTalk A.I. on Linkedin.

Share article on social media or email:

Illume Fertility Announces First Annual Fertility Fair to Take Place at Their Harrison Location on September 29th


Illume Fertility to Host First Annual Fertility Fair

“This fun, informative event is the perfect opportunity to connect with other members of the fertility community, learn more about fertility and family-building options, and meet our team,” says Dr. Ilana Ressler, one of the lead physicians at Illume Fertility’s Harrison location.

Illume Fertility, a leading modern fertility practice, has announced its first annual Fertility Fair to take place on Thursday, September 29th from 5:30pm – 8:00pm at their Harrison location, 440 Mamaroneck Avenue. Complimentary AMH fertility testing, an excellent measure of a woman’s ovarian reserve, will be offered, as well as the opportunity to speak one-on-one with some of Illume Fertility’s esteemed fertility experts.

Illume Fertility physicians available that evening to meet with community members will include Dr. Ilana Ressler, Dr. Laura Meyer, and Dr. Alexander Kucherov, who are the leading physicians at the Harrison location, and will speak to attendees about fertility treatment options. All Illume Fertility physicians are board-certified reproductive endocrinologists who deliver high-quality care to patients in the region by providing a full range of diagnostic services and treatment options for infertility, fertility preservation, and third party reproduction.

Raffle prizes will also be available at Illume’s Fertility Fair, including the opportunity to win a free egg freezing cycle, which typically costs between $11,000-$17,000, a free Yeti cooler, and more. Complimentary pizza and salads from Old World Pizza food truck will be available.

“We are excited to host our first annual Fertility Fair,” says Dr. Ilana Ressler, one of the lead physicians at Illume Fertility’s Harrison location. “This fun, informative event is the perfect opportunity to connect with other members of the fertility community, learn more about fertility and family-building options, and meet our team.”

For more information or to register for Illume Fertility’s Fertility Fair, visit https://illumefertilityfair.eventbrite.com/

About Illume Fertility

Illume Fertility, formerly RMA of Connecticut, is a leading modern fertility practice with an exceptional patient experience, providing care, guidance, and expertise to help patients achieve their fertility and family-building goals. Led by an award-winning team of eight highly credentialed Board Certified reproductive endocrinologists, many of whom have received Castle Connolly’s prestigious Top Doc award, Illume Fertility specializes in a range of assisted reproductive technologies (ART) including intrauterine insemination (IUI), in-vitro fertilization (IVF), preimplantation genetic testing (PGT), and Invocell (IVC). Illume Fertility’s internationally recognized Gay Parents To Be® program specializes in LGBTQ+ family building. For the last six years, Illume Fertility has been recognized as a Leader in Healthcare Equality by the Human Rights Campaign. Illume Fertility is one of the largest fertility clinics and egg donation centers in the region, also offering egg freezing, oncofertility preservation, and PCOS management, helping patients as young as 16. Illume Fertility is the only regional fertility clinic offering on-site holistic patient support services including nutrition counseling, individual and couples psychological counseling, acupuncture and yoga.

Share article on social media or email:

New Report Identifies Actions for Public Health Sector to Better Support Family Caregivers


News Image

Family caregivers are essential to safeguarding the health of millions of Americans, but they often perform this role at the expense of their own health, emotional well-being, and financial security, creating a silent public health crisis.

The National Alliance for Caregiving (NAC) in partnership with the National Association of Chronic Disease Directors (NACDD) issued a report that outlines immediate actions to help the public health community better serve family caregivers and improve their own health. “Chronic Disease Family Caregiving Through a Public Health Lens” puts forth actions for integrating caregivers and caregiving into public health practice and existing initiatives. The report is the result of a survey of 59 Chronic Disease Directors from U.S. states and territories, focus groups among the Chronic Disease Director network and a thought leader roundtable of experts in public health, aging, chronic disease, and family caregiving.

“Family caregivers are essential to safeguarding the health of millions of Americans, but they often perform this role at the expense of their own health, emotional well-being, and financial security, creating a silent public health crisis that deserves urgent attention,” said Jason Resendez, President and CEO of NAC. “We are proud to partner with the National Association of Chronic Disease Directors to shine a light on this crisis and to catalyze the action needed to address it.”

According to the NAC and AARP, more than one in five adults — a total of 53 million Americans — are unpaid family caregivers, creating ripple effects across families, communities, and the public health of the nation. Data from the Behavioral Risk Factor Surveillance System (BRFSS) finds that 40% of family caregivers report having two or more chronic diseases and over half (53%) of caregivers indicated that a decline in their own health has comprised their ability to provide care. Given a lack of affordable and accessible long-term services and adequate home and community-based supports, unpaid family caregivers are essential to supporting family members navigating chronic conditions, serious illnesses, and intellectual and development disabilities across the lifespan.

NAC and NACDD–supported by The John A. Hartford Foundation–worked with a wide range of experts at the intersections of public health and family caregiving to identify actions that can be taken by public health departments, states, and the federal government to strengthen their ability to meet the complex needs of family caregivers, including:

National-Level Recommendations

  • Improve data collection on the health status of family caregivers – including factors that influence their health, disparities and evaluation of caregiver support and education programs.
  • Integrate and improve the science of family caregiver research and literature within the schools of public health and professional associations to adapt current systems and prepare future public health workforces.
  • Develop and disseminate messaging about the essential role of family caregivers and the importance of maintaining their health to audiences including providers, practitioners, employers, and emergency response officials.

Community-Level Recommendations

  • Convene multi-sector stakeholders to strengthen, support, and mobilize communities and partnerships that can implement policies and practices that ensure the health and wellness of family caregivers as well as the persons receiving care.
  • Increase funding and capacity for home and community-based services that are critical for family caregivers, including home care and direct care services, transportation, congregate and home-delivered meals, and family caregiver support.

“The National Association of Chronic Disease Directors recognizes that family caregivers are key contributors to the health of their loved ones and friends,” said John W. Robitscher, MPH, CEO of NACDD. “We are pleased to partner with the National Alliance for Caregiving and The John A. Hartford Foundation to address the important public health issue of family caregivers, which affects the lives of millions of people—not only for those receiving care, but also the impact on the lives and health of the caregivers, themselves.”

The report can be found here at https://www.caregiving.org/public-health/.

The report and corresponding meetings were supported by funding from The John A. Hartford Foundation.

“Addressing the health and well-being of family caregivers must be a public health priority,” said Rani E. Snyder, MPA, Vice President of Program at The John A. Hartford Foundation. “This report from two highly expert organizations provides a clear pathway on how the public health sector can join the growing whole-of-society movement to better support people who are lynchpins of care for millions of older adults.”

#    #    #

About the National Alliance for Caregiving

Established in 1996, the National Alliance for Caregiving is a non-profit coalition of national organizations focusing on building health, wealth, and equity for family caregivers through research, innovation, and advocacy. We envision a society that values, supports, and empowers family caregivers to thrive at home, work, and life. Learn more at http://www.caregiving.org.

About the National Association of Chronic Disease Directors

NACDD and its more than 7,000 Members seek to strengthen state-based leadership and expertise for chronic disease prevention and control in states and nationally. Established in 1988, in partnership with the National Centers for Disease Control and Prevention, NACDD is the only membership association of its kind to serve and represent every chronic disease division in all states and U.S. territories. For more information, visit chronicdisease.org.

Share article on social media or email:

Ideal Option Partners with Marion County and others to Host Recovery Month Event


Ideal Option, a national leader in outpatient medication-assisted treatment for opioids, methamphetamine, alcohol and polysubstance, is partnering with Bridgeway Recovery Service, Marion County Health & Human Services, Marion County LEAD program, Iron Tribe Network, and Morrison Child & Family Services to help people in Salem get started in recovery.

According to data from the National Survey on Drug Use and Health, conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA) of the U.S. Department of Health & Human Services, Oregon nationally ranks:


  • 1st in prescription opioid misuse
  • 1st in methamphetamine use
  • 2nd in substance use disorder (nearly 1 in 5 Oregonians)
  • 50th in access to treatment

Recovery Starts Today! will take place on Friday, Sept. 23, 10 a.m. – 2 p.m. at the Ideal Option clinic in Salem located at 863 Liberty St NE. Attendees can surrender illicit substances and paraphernalia for safe disposal, learn about community resources, complete intake and, if desired, see a provider immediately to start medication-assisted treatment. For nearly all patients, costs are covered by Medicaid or private insurance.

This event is designed to empower those in the community who are struggling with the disease of addiction to come forward without fear of legal repercussions and begin their recovery with medication-assisted treatment.

For members of the community interested in a career in addiction medicine, Ideal Option will also be accepting applications and conducting in-person interviews during the event for medical assistants.

For questions about this event, email Senior Marketing Manager Olivia Easly at oliviaeasly@idealoption.net.

About Ideal Option Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped nearly 60,000 patients through a network of 81 office-based medication-assisted treatment (MAT) clinics across 10 states. With a mission to serve under-served communities, Ideal Option accepts all forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are also available.

Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism.

In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.

Share article on social media or email: